DelveInsight launched a new report on “Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Insights, Epidemiology, and Market Forecast-2030.”
Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) is a different kind of inflammatory arthritis. It falls under an umbrella category of diseases called spondyloarthritis, which includes different types of arthritis with one distinguishing feature. There is almost always inflammation in the spine.
Back pain is “the hallmark of Non-Radiographic Axial Spondyloarthritis, which sets it apart from any other type of inflammatory arthritis. “Non-radiographic” means the disease causes symptoms, but there is no visible damage on X-rays, the way there is with a related type of inflammatory arthritis called ankylosing spondylitis.
DelveInsight’s “Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Report 2030“ delivers an in-depth understanding of the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA), historical and forecasted epidemiology as well as the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/non-radiographic-axial-spondyloarthritis-nr-axspa-market
Non-Radiographic Axial Spondyloarthritis Symptoms:
“The prevalence of human leukocyte antigen B27 (HLA-B27) was similar for nr-axSpA and AS which is 86.4% for nr-axSpA vs. 89.1% for AS, 74.7% for nr-axSpA vs. 82.2% for AS, and 74.8% for nr-axSpA vs. 81.5% AS.”
Non-Radiographic Axial Spondyloarthritis Key pharma players involved:
Click here and request free sample pages.
Table of contents:
1 Key Insight2 Executive Summary of Non-Radiographic Axial Spondyloarthritis (nr-AxSpA)3 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Overview at a Glance4 Disease Background and Overview: Non-Radiographic Axial Spondyloarthritis (nr-AxSpA)5 Case Reports6 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Epidemiology and Patient Population7 United States Epidemiology8 EU5 Epidemiology9 Japan Epidemiology10 Current Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Treatment and Medical Practices11 Unmet needs12 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Marketed Drugs13 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Emerging Drugs14 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) 7MM Market Analysis15 United States16 EU-5 countries: Market Outlook17 Japan Market Outlook18 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Drivers19 Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market Barriers20 SWOT Analysis21 Reimbursement and market access22 Appendix23 DelveInsight Capabilities24 Disclaimer25 About DelveInsight
View our detailed report: https://www.delveinsight.com/report-store/non-radiographic-axial-spondyloarthritis-nr-axspa-market
About DelveInsightDelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/